Novo Nordisk Pharmatech
Research & Development
Novo Nordisk Pharmatech A/S is a global and leading manufacturer of pharmaceutical ingredients for the
pharmaceutical and biopharmaceutical industries. The company specialises in producing quaternary
ammonium compounds (Quats) used as active pharmaceutical ingredients (APIs) and excipients and
Recombinant Insulin for use in cell culture media to enhance cell growth and viability, and productivity.
Novo Nordisk Pharmatech helps the world´s largest pharmaceutical and biopharmaceutical industries
reducing their risk for raw materials by using pharma-grade products with a high level of consistency, purity,
quality, and reliability.
The mission is to enable better medicines by providing sustainable pharmaceutical materials through
innovative and customised solutions.